Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,411
Total Claims
$932K
Drug Cost
643
Beneficiaries
$1,450
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,124 General Surgery providers
-88%
Opioid rate vs peers
3.5% vs 30.2% avg
+474%
Cost per patient vs peers
$1,450 vs $253 avg
+106%
Brand preference vs peers
10.3% vs 5.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.5%
Opioid Rate
546
Opioid Claims
$7,622
Opioid Cost
11.5%
Long-Acting Rate
Brand vs Generic
Brand: 1,582 claims · $708K
Generic: 13,790 claims · $222K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 167 | $149K |
| Semaglutide | 93 | $101K |
| Fluticasone/Umeclidin/Vilanter | 110 | $90K |
| Rivaroxaban | 78 | $48K |
| Sitagliptin Phosphate | 61 | $45K |
| Tirzepatide | 27 | $32K |
| Empagliflozin | 34 | $31K |
| Insulin Nph Hum/Reg Insulin Hm | 21 | $28K |
| Budesonide/Formoterol Fumarate | 36 | $17K |
| Dulaglutide | 15 | $16K |
| Mirabegron | 38 | $12K |
| Potassium Chloride | 427 | $11K |
| Insulin Detemir | 12 | $10K |
| Umeclidinium Brm/Vilanterol Tr | 15 | $9,737 |
| Gabapentin | 518 | $9,544 |
Prescribing Profile
Patient Profile
75
Avg Age
53%
Female
0.98
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About